Literature DB >> 32386092

Management of colorectal cancer metastases to the liver, lung or peritoneum suitable for curative intent: summary of NICE guidance.

F Mohamed1, M Kallioinen2, M Braun3, S Fenwick4, M Shackcloth5, R J Davies6.   

Abstract

Entities:  

Year:  2020        PMID： 32386092     DOI： 10.1002/bjs.11609

Source DB:  PubMed          Journal:  Br J Surg        ISSN： 0007-1323            Impact factor:   6.939


× No keyword cloud information.
  8 in total

1.  Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Authors:  Marco Tonello; Dario Baratti; Paolo Sammartino; Andrea Di Giorgio; Manuela Robella; Cinzia Sassaroli; Massimo Framarini; Mario Valle; Antonio Macrì; Luigina Graziosi; Federico Coccolini; Piero Vincenzo Lippolis; Roberta Gelmini; Marcello Deraco; Daniele Biacchi; Francesco Santullo; Marco Vaira; Katia Di Lauro; Fabrizio D'Acapito; Fabio Carboni; Giuseppe Giuffrè; Annibale Donini; Paola Fugazzola; Pinuccia Faviana; Lorena Sorrentino; Antonio Scapinello; Paola Del Bianco; Antonio Sommariva
Journal:  Ann Surg Oncol       Date:  2021-11-16       Impact factor: 5.344

2.  Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) randomized controlled trial: a systematic review of published responses.

Authors:  Norman R Williams; Hannah Patrick; Francesca Fiorentino; Alexander Allen; Manuj Sharma; Mišel Milošević; Fergus Macbeth; Tom Treasure
Journal:  Eur J Cardiothorac Surg       Date:  2022-06-15       Impact factor: 4.534

3.  Establishment of a Tissue-Mimicking Surrogate for Pulmonary Lesions to Improve the Development of RFA Instruments and Algorithms.

Authors:  Louisa Bühler; Markus D Enderle; Nicolas Kahn; Markus Polke; Marc A Schneider; Claus Peter Heußel; Felix J F Herth; Walter Linzenbold
Journal:  Biomedicines       Date:  2022-05-10

4.  Reply to: The PulMiCC Trial Provides Control Data for Colorectal Lung Metastases Amenable to Local Treatments.

Authors:  Bobby Bhartia; Jim Zhong; Nilanjan Chaudhuri; Richard Milton; Jonathan Smith; James Lenton; Tze Min Wah
Journal:  Cardiovasc Intervent Radiol       Date:  2021-01-26       Impact factor: 2.740

5.  Case Report: First in Human Online Adaptive MR Guided SBRT of Peritoneal Carcinomatosis Nodules: A New Therapeutic Approach for the Oligo-Metastatic Patient.

Authors:  Luca Boldrini; Angela Romano; Lorenzo Placidi; Gian Carlo Mattiucci; Giuditta Chiloiro; Davide Cusumano; Veronica Pollutri; Marco Valerio Antonelli; Luca Indovina; Maria Antonietta Gambacorta; Vincenzo Valentini
Journal:  Front Oncol       Date:  2020-12-15       Impact factor: 6.244

6.  Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study.

Authors:  Pia Osterlund; Tapio Salminen; Leena-Maija Soveri; Raija Kallio; Ilmo Kellokumpu; Annamarja Lamminmäki; Päivi Halonen; Raija Ristamäki; Eila Lantto; Aki Uutela; Emerik Osterlund; Ali Ovissi; Arno Nordin; Eetu Heervä; Kaisa Lehtomäki; Jari Räsänen; Maija Murashev; Laura Aroviita; Antti Jekunen; Reneé Lindvall-Andersson; Paul Nyandoto; Juha Kononen; Anna Lepistö; Tuija Poussa; Timo Muhonen; Annika Ålgars; Helena Isoniemi
Journal:  Lancet Reg Health Eur       Date:  2021-01-29

Review 7.  Impact of the extent of lung resection on postoperative outcomes of pulmonary metastasectomy for colorectal cancer metastases: an exploratory systematic review.

Authors:  Elena Prisciandaro; Laurens J Ceulemans; Dirk E Van Raemdonck; Herbert Decaluwé; Paul De Leyn; Luca Bertolaccini
Journal:  J Thorac Dis       Date:  2022-07       Impact factor: 3.005

8.  Folinic Acid Potentiates the Liver Regeneration Process after Selective Portal Vein Ligation in Rats.

Authors:  Jorge Gutiérrez Sáenz de Santa María; Borja Herrero de la Parte; Gaizka Gutiérrez-Sánchez; Inmaculada Ruiz Montesinos; Sira Iturrizaga Correcher; Carmen Mar Medina; Ignacio García-Alonso
Journal:  Cancers (Basel)       Date:  2022-01-12       Impact factor: 6.639
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.